- UCLA physician-scientist named to Association of American Physicians
Dr. Michael Teitell has been named to the prestigious Association of American Physicians. Election to membership is among the most widely recognized international measures of scholarly excellence in academic medicine.
April 21, 2017 12:00 PMdetail
- Breast cancer survivors who are provided a tailored care plan are more likely to receive recommended care, UCLA study finds
Physicians of low-income breast cancer survivors are more likely to implement recommended survivorship care if the survivors also receive counseling and a tailored survivorship care plan, a study led by UCLA researchers has found.
April 18, 2017 1:00 PMdetail
- UCLA researcher awarded prestigious grant to study role of molecule in prostate cancer
UCLA researcher Andrew Goldstein has been awarded a research scholar grant from the American Cancer Society to fund his work on prostate cancer. Goldstein is an assistant professor in residence in the departments of Urology and Molecular, Cell and Developmental Biology, and a member of UCLA’s Jonsson Comprehensive Cancer Center and Broad Stem Cell Research Center.
April 18, 2017 9:00 AMdetail
- Who is the new face of throat cancer?
Younger and younger people are getting diagnosed with throat cancer each year, watch as UCLA's Dr. Abie Mendelsohn explains why.
April 17, 2017 3:00 PMdetail
- UCLA scientists combine a peptide with a nano cancer drug formulation to improve treatment effectiveness and prevent metastasis in pancreatic cancer
UCLA scientists have unlocked an important mechanism that allows chemotherapy-carrying nanoparticles to directly access pancreatic cancer tumors, thereby improving the ability to kill cancer cells and hence leading to more effective treatment outcome of the disease.
April 17, 2017 1:00 PMdetail
- UCLA scientist honored for advancing the understanding of how metabolism affects cancer
The AAAS has announced the winners of the prestigious 2017 AAAS Martin and Rose Wachtel Cancer Research Award, recognizing UCLA scientist Dr. Heather Christofk for her pioneering research into how metabolism can regulate and drive cancer.
April 11, 2017 11:00 AMdetail
- UCLA Jonsson Comprehensive Cancer Center scientists to present on latest cancer research advancements at AACR 2017
Scientists with UCLA’s Jonsson Comprehensive Cancer Center will present some of the most highly anticipated research at the 2017 American Association for Cancer Research (AACR) Annual Meeting. The event takes place at the Walter E. Washington Convention Center in Washington, D.C. from April 1 through April 5.
March 29, 2017 8:00 AMdetail
- Targeting cancer stem cells improves treatment effectiveness and prevents metastasis
Targeting cancer stem cells may be a more effective way to overcome cancer resistance and prevent the spread of squamous cell carcinoma—the most common head and neck cancer and the second-most common skin cancer—according to a new study by cancer researchers at the UCLA School of Dentistry
March 09, 2017 9:00 AMdetail
- Guidelines for treating brain metastases should be overhauled, UCLA study finds
An extensive study by UCLA researchers looking at current practice patterns among doctors treating people with three or more brain metastases—cancer cells that have spread from a primary tumor located in a different part of the body—found significant variation in treatment strategies, bringing to light the need for further research to guide physicians' decision making.
March 01, 2017 9:00 AMdetail
- DNA patterns can unlock how glucose metabolism drives cancer, study finds
Less aggressive cancers are known to have an intact genome—the complete set of genes in a cell—while the genome of more aggressive cancers tends to have a great deal of abnormalities. Now, a new multi-year study of DNA patterns in tumor cells suggests that these aberrant genetic signatures are not random but reflect selective forces in tumor evolution.
February 15, 2017 9:00 AMdetail
- Scientists discover why some cancers may not respond to immunotherapy
UCLA scientists have discovered that people with cancers containing genetic mutations JAK1 or JAK2 will have little or no benefit from the immunotherapy drug, pembrolizumab.
February 06, 2017 3:00 AMdetail
- UCLA cancer research pioneer honored for advancing the understanding of treatment-resistant melanoma
The AACR will honor Dr. Roger Lo, an accomplished physician-scientist widely recognized his work in understanding treatment-resistant melanoma, with its first annual Waun Ki Hong Award for Outstanding Achievement in Cancer Research
January 30, 2017 10:00 AMdetail
- Combination therapy for glioblastoma shows promising results in early-stage research
UCLA researchers have discovered that combining a vaccine developed at UCLA with other experimental therapies and FDA-approved treatments shows promise for reducing the size of advanced brain tumors. The immunotherapy, which is specifically intended to treat brain tumors, is called autologous tumor lysate-pulsed dendritic cell vaccination. It uses a portion of the patient's own brain tumor and is currently being tested in humans.
January 23, 2017 6:00 AMdetail
- The unexpected intersection between art and science
It’s a common misconception that art and science are vastly different; that they never overlap. But creativity is as essential to the scientific process as it is to the artistic method. Artists and scientists share a curiosity for the unknown, an appreciation for the beauty of the worlds they explore and an interest in creating something new.
January 19, 2017 10:30 AMdetail
- With $3.2 million grant from NIH, UCLA researcher to optimize selection of lung cancer patients for immunotherapy
Dr. Edward Garon, UCLA Jonsson Comprehensive Cancer Center member and associate professor of hematology and oncology at the David Geffen School of Medicine, has received a five-year, $3.2 million grant from the National Institutes of Health to advance the understanding of which people with non-small cell lung cancer respond to immunotherapy.
January 17, 2017 9:30 AMdetail
- UCLA-led study provides roadmap to more personalized cancer treatment
Researchers have found that people with advanced head and neck squamous cell carcinoma and the KRAS-variant inherited genetic mutation have significantly improved survival when given a short course of the drug cetuximab in combination with standard chemotherapy and radiation.
December 22, 2016 8:00 AMdetail
- Chinese herbal treatment shows signs of effectiveness in bone marrow recovery
Researchers have found that a Chinese herbal regimen called TSY-1 (Tianshengyuan-1) TSY-1 increased telomerase activity in normal blood cells but decreased it in cancer cells. These results indicate that telomerase-based treatments may be of significance in treatments for both blood cell deficiency and cancer.
December 14, 2016 2:00 PMdetail
- ‘Turbocharged artificial intelligence’ could personalize combination therapy in pediatric leukemia
A team of UCLA bioengineers has demonstrated that its technology may go a long way toward overcoming the challenges of treatment for acute lymphoblastic leukemia, among the most common types of cancer in children, and has the potential to help doctors personalize drug doses.
December 12, 2016 9:00 AMdetail
- UCLA researchers uncover new evidence linking inflammation and increased prostate cancer risk
Results of a new UCLA study suggest that inflammation increases overall risk for prostate cancer by increasing the available pool of progenitor cells that can develop into the disease
December 06, 2016 9:00 AMdetail
- Genetic factors control regenerative properties of blood-forming stem cells, UCLA studies show
UCLA researchers have published two studies that define how key genetic factors affect blood-forming stem cells by either accelerating or hindering the cells’ regenerative properties. The findings could one day lead to improved treatments for people undergoing common therapies for cancer such as chemotherapy and radiation.
December 05, 2016 12:00 PMdetail